IL-10 Treatment Is Associated with Prohibitin Expression in the Crohn’s Disease Intestinal Fibrosis Mouse Model

Table 1

The histologic colitis score in each group mice (𝑥±𝑠).

Group-week	𝑛	Histologic colitis score
12 wk
Control	6	1.33 ± 1.21
IL-10KO mice	6	5.67 ± 0.82^a
14 wk
Control	6	1.17 ± 0.75
IL-10KO mice	6	6.33 ± 0.82^a
IL-10 treated	6	5.17 ± 0.75^a
16 wk
Control	6	1.50 ± 1.38
IL-10KO mice	6	7.00 ± 0.90^a
IL-10 treated	6	4.33 ± 0.82^ab

^a𝑃<0.05, versus control group; ^b𝑃<0.05, versus IL-10KO mice group.